K. Foweraker

470 total citations
10 papers, 236 citations indexed

About

K. Foweraker is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, K. Foweraker has authored 10 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Rheumatology. Recurrent topics in K. Foweraker's work include Bone Tumor Diagnosis and Treatments (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Oral and Maxillofacial Pathology (2 papers). K. Foweraker is often cited by papers focused on Bone Tumor Diagnosis and Treatments (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Oral and Maxillofacial Pathology (2 papers). K. Foweraker collaborates with scholars based in United Kingdom and Australia. K. Foweraker's co-authors include George Giotopoulos, R.P. Symonds, Mark Plumb, Matthew Griffin, A. E. Osman, R. Jena, Sarah Jefferies, K.E. Burton, R.P. Symonds and Rodney J. Laing and has published in prestigious journals such as British Journal of Cancer, Journal of Neuro-Oncology and Clinical Radiology.

In The Last Decade

K. Foweraker

10 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Foweraker United Kingdom 7 109 80 56 48 39 10 236
Tsuyoshi Yanagi Japan 3 254 2.3× 76 0.9× 74 1.3× 45 0.9× 31 0.8× 6 318
Francisco Valcárcel Spain 10 135 1.2× 36 0.5× 35 0.6× 140 2.9× 37 0.9× 20 324
Jung Ho Im South Korea 9 115 1.1× 29 0.4× 36 0.6× 61 1.3× 23 0.6× 22 272
Hiroya Kato Japan 6 121 1.1× 164 2.0× 85 1.5× 38 0.8× 33 0.8× 10 367
Masamichi Suzuki Japan 8 55 0.5× 77 1.0× 14 0.3× 81 1.7× 37 0.9× 26 284
Naikang Zhou China 10 250 2.3× 48 0.6× 27 0.5× 141 2.9× 84 2.2× 40 401
Fernando M. Gómez Spain 10 158 1.4× 63 0.8× 20 0.4× 89 1.9× 45 1.2× 24 307
Ingeborg Taksdal Norway 9 166 1.5× 104 1.3× 101 1.8× 79 1.6× 36 0.9× 17 357
Ulisses Ribaldo Nicolau Brazil 9 111 1.0× 23 0.3× 30 0.5× 84 1.8× 57 1.5× 28 243
Fanny Dujardin France 9 110 1.0× 13 0.2× 111 2.0× 52 1.1× 30 0.8× 17 315

Countries citing papers authored by K. Foweraker

Since Specialization
Citations

This map shows the geographic impact of K. Foweraker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Foweraker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Foweraker more than expected).

Fields of papers citing papers by K. Foweraker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Foweraker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Foweraker. The network helps show where K. Foweraker may publish in the future.

Co-authorship network of co-authors of K. Foweraker

This figure shows the co-authorship network connecting the top 25 collaborators of K. Foweraker. A scholar is included among the top collaborators of K. Foweraker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Foweraker. K. Foweraker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jones, G., Aamir Khakwani, K. Foweraker, et al.. (2021). Factors associated with survival in small cell lung cancer: an analysis of real-world national audit, chemotherapy and radiotherapy data. Annals of Palliative Medicine. 10(4). 4055–4068. 4 indexed citations
2.
Lester, J., C. Esler, Elizabeth Toy, et al.. (2018). Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres. Clinical Oncology. 30(3). 144–150. 6 indexed citations
3.
Betts, Helen, et al.. (2018). Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers. Nuclear Medicine Communications. 40(1). 73–78. 10 indexed citations
4.
Morris, Katrina, John F. Golding, Claire Blesing, et al.. (2016). Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort. Journal of Neuro-Oncology. 131(1). 117–124. 40 indexed citations
5.
Foweraker, K., K.E. Burton, R. Jena, et al.. (2007). High-dose Radiotherapy in the Management of Chordoma and Chondrosarcoma of the Skull Base and Cervical Spine: Part 1 — Clinical Outcomes. Clinical Oncology. 19(7). 509–516. 50 indexed citations
6.
Giotopoulos, George, R.P. Symonds, K. Foweraker, et al.. (2007). The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. British Journal of Cancer. 96(6). 1001–1007. 93 indexed citations
7.
Foweraker, K., et al.. (2007). Conformal versus IMRT for Chordoma of the Skull Base and Cervical Spine. Clinical Oncology. 19(3). S28–S29. 3 indexed citations
8.
Foweraker, K., et al.. (2007). High Dose Photon Radiotherapy in the Management of Chordoma and Chondrosarcoma of the Skull Base and Cervical Spine. Clinical Oncology. 19(3). S28–S28. 4 indexed citations
9.
Symonds, R.P. & K. Foweraker. (2006). Principles of chemotherapy and radiotherapy. Current Obstetrics and Gynaecology. 16(2). 100–106. 15 indexed citations
10.
Abdi, Siamak, et al.. (2005). Metastatic spinal cord syndromes: imaging appearances and treatment planning. Clinical Radiology. 60(6). 637–647. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026